Cibus, Inc. (CBUS) Estados Financieros e Histórico

Cibus, Inc. (CBUS) — Precio $1.51 HealthcareBiotechnology — NASDAQ

Últimos resultados publicados:

Estados financieros detallados de Cibus, Inc. (CBUS): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.

Resumen del Análisis

Cibus, Inc. registró ingresos de $3.6M en el último ejercicio fiscal, con un CAGR de 5 años del -31.3%.

Márgenes de los últimos 12 meses: margen bruto 45.7%, margen operativo -12.4%, margen neto -22.6%.

Al precio actual de $1.51, CBUS presenta beneficios negativos (P/E no significativo) y un ROE del -320.60%. La capitalización bursátil es de $115M.

Cuenta de Resultados (10 años)

Año2016201720182019202020212022202320242025
Ingresos$399000$508000$236000$7.3M$23.9M$26.0M$157000$1.8M$4.3M$3.6M
Coste de Ventas$200000$551000$1.1M$9.3M$35.1M$28.6M$1.5M$395000$6.9M$5.9M
Beneficio Bruto$199000-$43000-$845000-$2.0M-$11.3M-$2.6M-$1.4M$1.4M-$2.6M-$2.3M
I+D$5.6M$11.6M$9.8M$12.2M$11.1M$11.3M$11.6M$42.4M$50.4M$44.2M
Generales y Administrativos$6.7M$14.7M$18.5M$24.1M$20.8M$15.4M$9.4M$28.9M$30.8M$26.9M
Gastos Operativos$12.3M$25.7M$27.3M$37.7M$32.6M$26.8M$21.0M$320.3M$74.4M$65.2M
Beneficio Operativo-$12.1M-$25.8M-$28.1M-$39.7M-$43.8M-$29.3M-$22.4M-$318.9M-$77.0M-$67.5M
EBITDA-$11.7M-$25.2M-$25.6M-$36.5M-$41.5M-$25.4M-$15.2M-$314.6M-$241.6M-$90.8M
Gastos por Intereses$5000$1000$1.3M$1.5M$1.4M$1.4M$87000$18.9M$34.2M$35.5M
Beneficio Antes de Impuestos-$12.1M-$26.0M-$27.9M-$39.6M-$44.8M-$29.2M-$16.9M-$337.6M-$282.7M-$132.2M
Impuestos0000000-$4000$29000$29000
Beneficio Neto-$12.1M-$26.0M-$27.9M-$39.6M-$44.8M-$29.2M-$16.9M-$267.6M-$251.4M-$127.1M
BPA$-21.86$-46.86$-45.46$-60.37$-66.16$-38.96$-18.36$-25.95$-10.83$-2.78
BPA Diluido$-21.86$-46.86$-45.46$-60.37$-66.16$-38.96$-18.36$-25.95$-10.83$-2.78
Acciones en Circulación (Diluidas)$553000$554375$613668$656113$677648$749515$919950$10.3M$23.2M$45.8M

Cuenta de Resultados (Trimestral)

Año2025-Q32025-Q42026-Q12026-Q2
Ingresos$615000$1.1M$1.7M$994000
Beneficio Bruto$615000$1.1M$484000-$168000
Beneficio Operativo-$15.4M-$13.5M-$12.1M-$12.9M
EBITDA-$15.3M-$21.2M-$10.9M-$11.5M
Beneficio Neto-$23.5M-$31.3M-$21.2M-$22.1M
BPA$-0.44$-0.59$-0.33$-0.29
BPA Diluido$-0.44$-0.59$-0.33$-0.29

Balance (10 años)

Año2016201720182019202020212022202320242025
Caja y Equivalentes$5.0M$56.7M$93.8M$58.6M$17.3M$13.8M$3.4M$32.7M$14.4M$9.9M
Inversiones a Corto0000$11.7M00000
Cuentas por Cobrar$157000$167000$46000$1.1M$4.9M00$530000$1.0M$703000
Inventario000$2.6M$1.4M00000
Activos Corrientes$5.5M$57.5M$95.5M$63.5M$39.6M$15.2M$4.1M$35.2M$16.9M$12.1M
Inmovilizado Material$11.0M$14.4M$21.9M$23.2M$22.9M$21.7M$18.1M$37.5M$44.7M$27.9M
Fondo de Comercio0000000$434.9M$253.5M$232.5M
Activos Intangibles000000$158000$35.4M$33.6M$31.7M
Activos Totales$16.6M$72.2M$118.8M$88.1M$63.3M$37.2M$22.4M$544.4M$350.1M$305.0M
Cuentas por Pagar$357000$1.0M$818000$1.1M$929000$1.3M$340000$6.1M$6.0M$8.1M
Deuda a Corto0000000$833000$436000$3.2M
Pasivos Corrientes$2.9M$4.3M$7.0M$7.2M$6.9M$4.9M$1.7M$21.3M$19.9M$16.9M
Deuda a Largo0000$1.5M00$536000$226000$235.0M
Pasivos Totales$3.5M$14.7M$25.4M$25.6M$26.5M$23.1M$15.2M$206.1M$252.2M$283.2M
Reservas-$28.6M-$54.5M-$82.4M-$122.1M-$166.9M-$196.1M-$212.2M-$479.8M-$731.2M-$858.3M
Patrimonio Neto$13.1M$57.5M$93.4M$62.5M$36.9M$14.1M$7.2M$293.5M$92.2M$21.8M
Deuda Total0$10.1M$18.5M$18.6M$19.8M$17.9M$13.9M$24.6M$36.3M$268.0M
Deuda Neta-$5.0M-$46.5M-$75.3M-$40.0M-$9.2M$4.1M$10.5M-$8.1M$21.9M$258.0M
Capital Circulante$2.6M$53.2M$88.5M$56.3M$32.6M$10.3M$2.5M$13.9M-$2.9M-$4.8M

Balance (Trimestral)

Año2025-Q32025-Q42026-Q12026-Q2
Caja y Equivalentes$23.9M$9.9M$30.3M$20.4M
Activos Totales$330.2M$305.0M$324.2M$313.4M
Pasivos Totales$278.2M$283.2M$288.7M$298.6M
Patrimonio Neto$50.4M$21.8M$35.5M$14.8M
Deuda Total$33.9M$268.0M$276.2M$32.7M

Flujo de Caja (10 años)

Año2016201720182019202020212022202320242025
Beneficio Neto-$12.1M-$26.0M-$27.9M-$39.6M-$44.8M-$29.2M-$16.9M-$267.6M-$282.7M-$127.1M
Amortizaciones$345000$551000$1.1M$1.6M$1.9M$2.3M$1.5M$4.7M$6.9M$5.9M
Compensación en Acciones$948000$12.1M$4.4M$9.2M$5.0M$2.1M$4.0M$16.1M$10.8M$8.2M
Cambio en Capital Circulante$1.6M$552000$2.2M-$3.1M-$5.7M$7.5M-$2.9M$961000$383000$2.3M
Flujo de Caja Operativo-$9.2M-$12.8M-$20.3M-$32.0M-$43.7M-$18.8M-$19.4M-$46.2M-$58.0M-$50.6M
Inversiones (CapEx)-$10.4M-$779000-$1.8M-$3.0M-$1.8M-$497000-$1.5M-$4.3M-$808000-$578000
Adquisiciones0000000$59.4M00
Recompra de Acciones00-$2300000000000
Dividendos Pagados0000000000
Flujo de Caja Libre-$19.7M-$13.6M-$22.1M-$34.9M-$45.5M-$19.3M-$20.9M-$50.5M-$58.9M-$51.2M

Flujo de Caja (Trimestral)

Año2025-Q32025-Q42026-Q12026-Q2
Flujo de Caja Operativo-$11.7M-$13.4M-$11.5M-$9.4M
Inversiones (CapEx)-$108000-$86000-$115000$42000
Flujo de Caja Libre-$11.8M-$13.5M-$11.6M-$9.4M
Dividendos Pagados0000
Compensación en Acciones$1.9M$1.8M$1.6M$1.5M

Crecimiento y Márgenes (10 años)

Año2016201720182019202020212022202320242025
Crecimiento Ingresos (anual)+27.3%-53.5%+2991.5%+226.9%+9.0%-99.4%+1057.3%+134.6%-14.6%
Crecimiento Beneficio Neto (anual)-115.0%-7.4%-42.0%-13.2%+34.9%+42.2%-1484.4%+6.1%+49.4%
Crecimiento BPA (anual)-114.4%+3.0%-32.8%-9.6%+41.1%+52.9%-41.3%+58.3%+74.3%
Cambio en Acciones (anual)+0.2%+10.7%+6.9%+3.3%+10.6%+22.7%+1021.2%+125.1%+97.0%
Crecimiento FCF (anual)+31.0%-62.9%-58.0%-30.2%+57.5%-8.2%-142.0%-16.5%+13.1%
Margen Bruto49.9%-8.5%-358.1%-27.2%-47.3%-9.9%-877.1%78.3%-60.9%-62.8%
Margen Operativo-3034.8%-5076.6%-11913.1%-543.8%-183.8%-112.9%-14248.4%-17550.0%-1805.8%-1853.9%
Margen EBITDA-2941.4%-4954.3%-10830.1%-500.5%-174.1%-97.9%-9687.9%-17313.4%-5669.5%-2494.3%
Margen Neto-3029.1%-5114.2%-11820.8%-542.9%-188.0%-112.4%-10758.6%-14729.1%-5898.4%-3492.3%
Margen FCF-4927.6%-2670.1%-9364.0%-478.6%-190.6%-74.3%-13301.9%-2781.0%-1380.8%-1406.1%
Tasa Impositiva Efectiva-0.0%-0.0%-0.0%-0.0%-0.0%-0.0%-0.0%0.0%-0.0%-0.0%

Datos por Acción (10 años)

Año2016201720182019202020212022202320242025
FCF por Acción$-35.55$-24.47$-36.01$-53.22$-67.08$-25.76$-22.70$-4.90$-2.53$-1.12
Dividendo por Acción$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Acciones en Circulación (Básicas)$553000$554375$613668$656113$677648$749515$919950$10.3M$23.2M$45.8M

Qué mirar en Biotech

La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.

Rentabilidad

Rentabilidad sobre capital-320.60%
Rentabilidad sobre capital invertido-17.82%
Rentabilidad sobre activos-31.33%
Margen bruto45.73%
Margen operativo-1240.90%
Margen neto-2258.89%

Salud financiera

Deuda / Patrimonio2.21
Ratio corriente1.62

Ratios Clave (10 años)

Año2016201720182019202020212022202320242025
P/E-25.73-25.02-11.39-5.81-3.19-2.73-0.40-0.76-0.26-0.63
P/VC23.7111.313.403.683.885.650.940.690.703.65
P/V779.611279.541346.9531.525.993.0743.36111.4915.1521.88
Margen Bruto49.9%-8.5%-358.1%-27.2%-47.3%-9.9%-877.1%78.3%-60.9%-62.8%
Margen Operativo-3034.8%-5076.6%-11913.1%-543.8%-183.8%-112.9%-14248.4%-17550.0%-1805.8%-1853.9%
Margen Neto-3029.1%-5114.2%-11820.8%-542.9%-188.0%-112.4%-10758.6%-14729.1%-5898.4%-3492.3%

Empresas relacionadas: ACRV · BMEA · CAMP · IMUX · MNOV · PMVP · RLMD

Explorar sector: Healthcare · Biotechnology

Más secciones de CBUS: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos

Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones